Purpose The purpose of this study was to identify the genes, biochemical signaling pathways, and biological themes involved in the pathogenesis of retinopathy of prematurity (ROP). Methods Next-generation sequencing (NGS) was performed on the RNA transcriptome of rats with the Penn et al. (Pediatr Res 36:724-731, 1994) oxygeninduced retinopathy model of ROP at the height of vascular abnormality, postnatal day (P) 19, and normalized to age-matched, room-air-reared littermate controls. Eight custom-developed pathways with potential relevance to known ROP sequelae were evaluated for significant regulation in ROP: The three major Wnt signaling pathways, canonical, planar cell polarity (PCP), and Wnt/Ca 2? ; two signaling pathways mediated by the Rho GTPases RhoA and Cdc42, which are, respectively, thought to intersect with canonical and non-canonical Wnt signaling; nitric oxide signaling pathways mediated by two nitric oxide synthase (NOS) enzymes, neuronal (nNOS) and endothelial (eNOS); and the retinoic acid (RA) signaling pathway. Regulation of other biological pathways and themes was detected by gene ontology using the Kyoto Encyclopedia of Genes and Genomes and the NIH's Database for Annotation, Visualization, and Integrated Discovery's GO terms databases. Results Canonical Wnt signaling was found to be regulated, but the non-canonical PCP and Wnt/Ca 2? pathways were not. Nitric oxide signaling, as measured by the activation of nNOS and eNOS, was also regulated, as was RA signaling. Biological themes related to protein translation (ribosomes), neural signaling, inflammation and immunity, cell cycle, and cell death were (among others) highly regulated in ROP rats. Conclusions These several genes and pathways identified by NGS might provide novel targets for intervention in ROP.
Introduction
Complex interactions occur between the neural retina and its vascular supply in normal retinal development and in retinal disease [1] . Retinopathy of prematurity (ROP) occurs when the prematurely born infant is exposed to supplemental oxygen [2] [3] [4] [5] [6] [7] during ages at which the retina [8] [9] [10] [11] [12] [13] [14] [15] [16] and its vascular supply [17] are both immature and the eye is growing rapidly [18] [19] [20] [21] . Although a critical role for the neural retina in the pathogenesis of ROP has become increasingly recognized [22, 23] , the clinical hallmark of active ROP continues to be abnormal retinal vasculature: tortuous arterioles, dilated venules, and vitreoretinal neovascularization (NV) [24] . Nevertheless, lifelong retinal dysfunction is found even if the ROP was so mild that the vascular disease resolved spontaneously [25] [26] [27] [28] [29] . Furthermore, the most common clinical sequela of ROP is the altered growth of the eye and its refractive components [18-21, 30-36]. The mechanisms underpinning the altered eye growth in ROP remain poorly understood.
It follows that, to date, most of the ROP research, in patients and in animal models, has been focused on the vascular abnormalities. The critical pro-angiogenesis messenger vascular endothelial growth factor (VEGF) has been targeted in severe, active ROP, with promising therapeutic success [37] . Recently, alternative pathways that impact both vascular and neural tissues rather directly, such as the Wnt signaling pathway, have also been implicated in ROP [38] . The continued discovery of new pathways important to ROP pathology suggests that there are still many more. Because it is so complex, a modern approach is needed to consider the biological factors that lead to the distinct pathology of the ROP eye. Next-generation sequencing (NGS) assesses the relative expression of every gene in an organism's genome and can, therefore, identify a large number of potential targets for intervention. NGS is an hypothesis generator.
We used NGS to evaluate the transcriptome (mRNA) of the Penn et al. [39] ''50/10'' oxygen-induced retinopathy (OIR) rat model of ROP at the height of vasculopathy (postnatal day 19). Thus, we determined all genes that were regulated in the eye afflicted by OIR at this cross-section in time. Our data supplement those already obtained by microarray [40] . In addition to ascertaining individually regulated genes, we conducted gene analysis on pathways annotated by the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the NIH's Database for Annotation, Visualization and Integrated Discovery (DAVID)'s GO terms. We also tested eight systems which published data and our own preliminary data suggest might be intimately involved in the ROP disease process for likely involvement in ROP pathogenesis (Table 1) .
First, we looked at canonical Wnt signaling. This pathway is, by definition, activated when a Wnt ligand binds to a frizzled (Frz) receptor on a cell membrane [41] . Disruption in the canonical Wnt pathway results in reduced neovascularization (NV) in the Smith et al. [42] mouse model of ROP [43] . In patients with familial exudative vitreoretinopathy (FEVR), particular genetic mutations lead to the failure of activation of the Frz receptor. Infants with severe FEVR (and Norrie Disease, ND) have tortuous, dilated retinal vessels, an avascular peripheral retina, subretinal exudation, and extraretinal NV with consequent vitreoretinal traction, features common in ROP. Indeed, recent data suggest that as many as 10 % of severe ROP cases are complicated by Wnt signaling disorders [44, 45] . Interestingly, as in mild ROP, in mild FEVR/ND, there may be significant retinal and visual dysfunction [46] .
Wnt signaling coopts the ubiquitous, versatile, and complex effectors of biochemical activity, the Rho family of GTPases [47] . The Rho GTPases belong to the ''rat sarcoma'' (Ras) superfamily. They act as molecular switches. The function of Rho GTPases depends upon their various downstream effectors [48] . There is accumulating evidence that misregulated Rho [78] . Thus, we also looked at the two major non-canonical Wnt pathways (PCP, Wnt/Ca 2? ), and the downstream RhoA and Cdc42 GTPase signaling pathways.
Next, we considered the nitric oxide (NO) signaling pathway, a signaling system in neurovascular tissues including the retina [79] [80] [81] . Regulation of NO was recently shown to be effective at preventing neuropathology in the early stages of a mouse model of diabetic retinopathy [82] . The generation of NO is controlled by a family of enzymes, called NO synthase (NOS), which catalyze its production from L-arginine: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). nNOS is the isoform most involved in the regulation of neural function, while eNOS is associated with vascular changes, and iNOS is inducible only in pathological conditions [83] . All classes of retinal neurons are likely affected by NO, principally via its activation of soluble guanylyl cyclase (sGC) [84] . NO increases the voltage range of exocytosis in photoreceptors [85, 86] , reduces light responses in horizontal cells [87, 88] , increases the circulating current of bipolar cells [89, 90] , uncouples gap junctions between AII amacrine cells and cone bipolars [91] , and more. NO also impacts the retinal vasculature. For instance, NO is involved in helping the choroid respond to changes in oxygen tension [92] . Changes in NOS activity are also associated with profound changes to blood vessels in retinal diseases such as diabetic retinopathy and glaucoma [93] .
Finally, mindful of the fact that the most common clinical sequela of ROP is refractive error, we also looked at retinoic acid (RA) signaling, a candidate pathway for the mediation of myopia; notably, though, expression of the gene encoding the retinoic acid receptor (RARA) is not likely altered in myopia [94] , RA levels are higher in the choroid than any other tissue in the body. Increased levels of RA in the choroid are associated with decreased eye growth while, paradoxically, increased RA in the neural retina is associated with increased eye growth [95] . Vitamin A supplementation at preterm ages is beneficial to retinal function in ROP [96] . It is, therefore, plausible that changes in RA production (and possibly its receptors) are important controllers of eye growth and refractive error in ROP. Furthermore, nNOS is associated with rapid swelling of the choroid and changes in the sclera that alter the size and shape of the ametropic chick eye [97] [98] [99] . NOS is strongly upregulated in mammalian form-deprivation myopia, too, although such dramatic changes in the choroid and sclera are not found [100] . NO nevertheless remains another compelling candidate for controlling eye growth and refractive development [95] .
In addition to testing these specific hypotheses, we make the gene expression database available (see online supporting materials) for other laboratories to inspect and test their own hypotheses against.
Methods

Preparation of genetic material
The retinae of 10, 19-day-old Sprague-Dawley rats were studied. Half had retinopathy induced following the Penn et al. ''50/10'' paradigm [101] , as previously described [102] [103] [104] [105] . The other half were room-air-reared (RAR) littermates. Briefly, newborn ROP rat pups were exposed to alternating 24-h periods of 50 and 10 % oxygen from the day of birth until P14, when they were returned to room air (*21 % oxygen). On P19, when neovascularization and arteriolar tortuosity are most severe, the ROP rats and RAR controls were killed with an overdose of sodium pentobarbital and their retinae quickly dissected from the eye. These experiments complied with the ARVO Statement for the Use of Animals in Research.
Total RNA was obtained using an RNA Mini Prep Kit (Qiagen, Valencia CA). The cells of each retina were disrupted and homogenized by pulling samples, immersed in b-mercaptoethanol and Buffer RLT, through sequentially higher-gauged needles. The lysate was centrifuged, the supernatant removed and transferred to a clean container, and 70 % ethanol added to precipitate the RNA. The sample was then centrifuged on a column to trap the RNA, rinsed with Buffer RW1 and RPE, and then the RNA was eluted using RNAse-free water. RNA purity and concentration were determined using a spectrophotometer (NanoDrop 8000, Thermo Scientific, Wilmington, DE, USA). The contribution of each retina to the final analysis was normalized within group (ROP, RAR); volume was scaled by the inverse of concentration. Thus, each rat contributed the same amount of RNA to the respective group analysis.
Next-generation sequencing and analysis
Whole-genome RNA next-generation sequencing (RNA-seq) was performed at the Harvard Medical School Biopolymers Core Facility (Boston, MA, USA) using a HiSeq2000 Sequencer (Illumina, San Diego, CA, USA). Prior to sequencing, 4 lg of RNA were isolated from each sample (ROP, RAR) using a Dynabeads mRNA Purification Kit (Life Technologies, Carlsbad, CA, USA) and processed using the NEBNext mRNA Sample Prep Reagent Set 1 (New England Biolabs, Ipswitch, MA, USA). The samples were next run on a Bioanalyzer 2100 High Sensitivity DNA chip (Agilent, Santa Clara, CA, USA) and then in a SYBR-based qPCR assay to verify the presence of adapters. RNA library samples of ROP and RAR were sequenced with 100 base single-end reads. Reads were mapped to the rattus norvegicus reference genome (Baylor 3.4/rn4) using Tophat 2.0.1 software (http:// tophat.cbcb.umd.edu/). Quantification for gene expression was performed as reads per kilobase of exon per million mapped reads (RPKM) [106] . A summary of the mapped reads is in Supplementary Table 1 .
Derivation of pathways
To evaluate the eight custom pathways (Table 1) , diagrams were produced (Figs. 1, 2, 3, 4, 5, 6, 7, 8).
Qiagen pathway maps were used as an initial template for all pathways except the relatively simple RA synthesis pathway, which is outlined by Cvekl and Wang [107] . Additionally, the PCP pathway map was expanded using information compiled by Katoh [108] . The NCBI gene database was used to confirm the existence and name of each gene in the rat. Protein interactions in all pathways were confirmed to be accurate to current understanding using recent literature . Isoforms were removed if they were not present in the retina or if their retinal expression was known to be very low. The up-or down-regulation of each gene in each pathway was culled from the NGS database.
Although several papers have employed gene chips to analyze expression in murine OIR models of ROP [144] [145] [146] [147] , only one (to our knowledge), Recchia et al.
[40], did so in the 50/10 ROP rat. Thus, in our study, genes were deemed ''regulated'' if the fold change (FC) was greater than 1.7, up (?0.77 log 2 ) or down (-0.77 log 2 ), for easy comparison to Recchia et al.'s gene chip results wherein this was the cutoff used for significance. The proportion of regulated genes in the ROP genome, G reg , was calculated. To determine whether the activation of each pathway (Table 1) was significantly altered, the probability of finding the observed number (or more) of regulated genes was calculated using the inverse cumulative binomial probability distribution. We assumed that G reg represented the expected proportion of regulated genes in the pathway. Since eight pathways were tested, marginal significance was defined as P \ 0.05, but full significance only if P \ 0.00625. After testing our hypotheses about the eight custom pathways, gene ontology analysis for ''significant genes'' (±0.77 log 2 ) was performed using KEGG and NIH DAVID to identify additional regulated biological themes.
Results
Many individual genes were significantly regulated, up and down, in ROP retinae. Table 2 shows those protein-coding genes that were regulated more than ±6.64 log 2 (100-fold) in ROP. The complete results are given in Supplementary Table 2. In supplementary Figure 1 , histograms of the pre-alignment quality of all bases from all reads in the ROP and RAR samples (top) and the qualities of all the reads in ROP and RAR (bottom) are shown; quality of a read is defined as the average of qualities of the bases comprising the read.
Literature-based pathway analyses (Table 1) Canonical Wnt signaling (Fig. 1 ) was significantly altered in ROP. Six isoforms of Wnt were significantly upregulated (Wnt2b, Wnt3, Wnt4, Wnt6, Wnt10a, and Wnt10b) and four were significantly down-regulated (Wnt7a, Wnt7b, Wnt11, and Wnt16). However, the lipidbinding Wnt inhibitory factor, Wif1, was up-regulated and may have counteracted some of the increased Wnt activity. In addition, three dickkopf-related protein encoding genes (Dkk1, Dkk2, and Dkk4) and associated kremen gene (Kremen1), which together inhibit low-density lipoprotein receptors (LRPs), were also up-regulated. Indeed, Lrp5, which is a coreceptor for Fzd binding of Wnt, was downregulated. Consistent with overall down-regulation of the Wnt pathway, two isoforms of Fzd (Fzd2, Fzd4) were underexpressed; none were up-regulated. The downstream cytoplasmic phosphoprotein encoding dishevelled-like gene (Dvl3) was subsequently down-regulated.
The non-canonical PCP Wnt signaling pathway (Fig. 2) was not significantly regulated, although two of the ligands most notably involved in the activation of this pathway (Wnt4, Wnt5b) were markedly up- regulated. This is one pathway by which Wnt and Rho GTPase activity interact (via Daam) [47] , and although Daam2 was markedly down-regulated, there was no significant change in Rho expression.
Despite the down-regulation of Fzd2, the frizzled isoform most important in the activation of the noncanonical Wnt/Ca 2? pathway, and despite significant changes in the expression of several G-proteins, both up and down, there was no significant change in the overall expression of this pathway (Fig. 3) .
The Rho GTPase pathways initiated by Rho and Cdc42 are, respectively, shown in Figs. 4 and 5. As mentioned, Rho was not regulated in ROP. Despite marked regulation in several genes in these pathways (as indicated), neither Rho nor Cdc42 signaling were regulated.
NO activity, indicated by the combined expression of the nNOS (Fig. 6) and eNOS (Fig. 7) signaling pathways, was marginally significantly regulated (P = 0.029). Individually, regulation in the nNOS pathway was marginally significant but in the eNOS pathway not quite so (Table 1) . Members of the glutamate (NMDA) receptor superfamily (Grin), which complex to form ligand-gated calcium channels that are instrumental to the activation of nNOS (Nos1), were down-regulated in ROP (Grin2a, Grin2b, Grin2c, Grin2d; Fig. 6 ). Nevertheless, despite the putative decrease in Ca 2? flux in ROP retinal neurons, Nos1 was not significantly regulated. Of note, the downstream Rho GTPase, Rasd1, was significantly downregulated. In contrast, despite the overall pathway not being significantly regulated, eNOS (Nos3) itself was significantly overexpressed in ROP. Therefore, the total amount of NO catabolized from L-arginine by NOS was likely higher in ROP than RAR retinae.
Lastly, RA synthesis ( Fig. 8 ) was marginally significantly regulated in ROP. Multiple enzymes in the retinoid cycle were significantly regulated, some down (Adh4, Rdh5, Aldh1a3, Aldh8a1) and one up (Adh1). The gene that encodes the RA receptor (Rara) was not, itself, regulated.
Digital gene analyses
The mRNA expression profile was tested against databases of biological themes, including KEGG and DAVID's GO terms. The significance of each theme was calculated following the Benjamini correction for false discovery. Details of the significantly enriched biological themes are given in Tables 3 (KEGG) and 4 (DAVID).
Discussion
This data set, obtained at the height of retinal vascular abnormalities (i.e., tortuosity and neovascularization), should provide insights into those genes and pathways activated in the pathogenesis of ROP. It may Fig. 6 Major elements of nitric oxide signaling in neurons (nNOS). Symbology as in Fig. 1 
complement an earlier data set obtained in the 50/10 ROP rat by gene chip [40] . Interestingly, while there is substantial overlap between that study and this NGS study, there is also substantial divergence. In addition to the digital gene expression analysis against standardized databases, we investigated genes in specific pathways of interest to our and other groups.
For instance, the Wnt signaling pathway has been recently implicated in ROP and we found it to be regulated in our sample. However, the KEGG pathway database does not differentiate between the canonical Wnt pathway and the alternative PCP and Wnt/Ca 2? pathways. Thus, we studied these pathways individually and found that while, unsurprisingly, a significant proportion of the genes in the Fig. 7 Major elements of nitric oxide signaling in blood vessels (eNOS). Symbology as in Fig. 1 and 6 canonical pathway were regulated, a less marked proportion of the PCP and Wnt/Ca 2? pathways were activated (Table 1; Figs. 1, 2, 3) . Indeed, while the PCP pathway showed some evidence of regulation (P = 0.056), the Wnt/Ca 2? pathway showed almost no regulation beyond that which would be expected by chance (P = 0.41).
It is increasingly clear that Wnt signaling coops Rho GTPase signaling. Therefore, we looked at Rho GTPase activity in the Rho pathway, which has several upstream elements that are regulated by Wnt signaling, and in the Cdc42 pathway, which has equivocal association with Wnt signaling. Neither were regulated.
We have found that, early in the pathogenesis of diabetic retinopathy (DR), NO signaling seems to become activated and be associated with retinal dysfunction [82] . Since both DR and ROP are neovascular diseases, we examined whether genes involved in the activation of NOS, the enzyme that generates NO, were regulated. They were (Table 1) : probably those in neurons (P = 0.034) and possibly those in blood vessels (P = 0.073). Since the retinal blood vessels and neurons are in close physical proximity and mature together, NO may help synchronize the neurovascular congruence in the retina [148] . While the evidence suggested that the nNOS pathway was down-regulated, nNOS itself (Nos1) was not regulated. Conversely, the eNOS pathway was not regulated; however, eNOS itself (Nos3) was up-regulated. Since NO freely diffuses through most cells, neurons may have received increased NO from blood vessels.
In addition, we recently completed a study of the refractive state of the ROP rat's eye [149] . Relative to the control rat, the ROP rat is a myope. Important in the regulation of refractive development is RA, and therefore, we looked at RA signaling. We found that it was significantly regulated in ROP (Table 1) . Furthermore, we note that the SIX family of sine oculis homeodomain-containing DNA-binding proteins, in particular Six3 and Six6, are critical mediators of vertebrate eye growth and development [150] and that one of the most down-regulated genes in the ROP rat retina is Six6os1 (Table 2 ). This ''opposite strand'' natural antisense transcript (NAT) to Six6 is an important mediator of Six6's activity. Six6 and Six6os are expressed almost uniquely in the neural retina. The degree of sequence similarity between murine and human of Six6os is quite high [151] . Also, keratocan (Kera), a gene known for its involvement in corneal development [152] , was highly overexpressed in ROP retinae (Table 2 ). This might contribute to the increased corneal curvature frequently noted in ROP myopia [153] .
In our analysis, we defined ''marginally significant regulation'' of a pathway as having a number of regulated constituent genes that were less than five percent likely to have occurred by chance given the total number of genes that were regulated in ROP. However, we note that statistically significant regulation of a pathway does not imply that the aggregate activity of the pathway is up or down (or even changed at all). For example, the canonical Wnt signaling pathway, the most regulated of our eight literaturebased (i.e., hypothesis-driven) pathways, had eleven up-regulated genes and eight down-regulated genes. Further complicating matters, some of the genes that were up-regulated inhibit the activation of other genes in the pathway. Thus, we are tempted to claim that the net effect on Wnt pathway activation is ''down,'' but really, the result is equivocal. Focusing on the ligands, in comparison with the mouse model of ROP in which Wnt3a, 7a, and 10a are all down-regulated [43], in our rat data, expression of 3a was not altered (although expression of 3 was up-regulated), 7a was significantly down-regulated, and 10a was significantly upregulated.
The most significantly regulated biological theme in the KEGG digital gene expression analysis was ''Ribosome'' (Table 3) . Ribosomes are involved in the translation of mRNA into proteins. Ribosomes are involved in so many cellular processes that it is difficult to conclude what their role in ROP might be from this data point alone. Rather, these data suggest that a proteomic approach is likely to yield much new and valuable information.
The KEGG ''Neuroactive ligand receptor interaction'' theme (Table 3) , which contains many G-protein-coupled receptors (GPCRs), was also significantly regulated. GPCRs were excluded from our custom pathway analyses because they are so numerous. If these had been included in the custom analyses, the results for the Rho, Cdc42, and eNOS pathways would have been altered. In any event, it is clear that neurotransmitter activity is importantly altered in the ROP rat retina. Certainly, the ERG results in both animal models and patients with ROP indicated that neural retinal dysfunction is a feature of ROP that persists for life. Cytokines, proteins that act as intercellular messengers, are involved in varied cellular functions including immune processes like inflammation, repair, and maintenance of homeostasis. They are also involved in cell growth, differentiation, and death, including in endothelial cells. Several groups of cytokines, distinguished by their structure, exist. ''Cytokine-cytokine receptor interaction'' was regulated in the KEGG database, as shown in Table 3 .
Seventy GO terms were regulated in the NIH's DAVID database, following Benjamini correction for multiple tests (Table 4 ). These terms encompass a variety of biological systems, but two classes seem particularly pronounced due to their repeated appearance: immunity and cell cycle. There a small but increasing body of evidence that suggests inflammatory and immune system pathways are involved in neovascular retinal diseases. In particular, a role for the complement system has been recently reviewed [154] . Thus, immune system activity may represent an emerging target for ROP therapy. With respect to the cell cycle, there is little literature to suggest significant changes therein are a feature of ROP. However, changes in mitosis events in endothelial cells, regulated by VEGF and perhaps downstream NO signaling, are associated with the increased arteriolar tortuosity in ROP [155] .
There are a few limitations of this kind of study. For instance, while it is fortunate that the output of the HiSeq 2000 sequencing system enables rapid profiling and deep investigation of the transcriptome, we did not perform sequencing on technical replicates. Thus, the degree of certainty in the activation values is somewhat low. Furthermore, while we did have biological replicates in the form of pooled samples, they were sequenced ensemble, which is a less powerful (but much less costly) approach than sequencing individuals' RNA. The declining costs of NGS will make such replication more feasible in needed future studies of this variety. And an additional, final note: the regulation of any given biological theme found to be significant herein may indeed be important to the pathogenesis of ROP, but it may also be compensatory to the pathology. Thus, while it is tempting to imagine interventions that would normalize one or more of the several regulated biological themes discovered herein, caution should be applied since the eye may already be compensating for some other, deleterious biochemical response. In this case, normalizing activation of the signaling pathway could potentially worsen outcomes.
Since we assayed only one time point, there is no evidence in our current data set to distinguish between pathological and compensatory activation of genes. 
